Inventiva (IVA) Cash from Investing Activities (2019 - 2025)
Inventiva (IVA) recorded quarterly Cash from Investing Activities of -$28.1 million in Q2 2025, down 10166.56% quarter-over-quarter from -$273426.3 in Q4 2022.
Inventiva (IVA) Cash from Investing Activities (2019 - 2025) Analysis & Trends
Inventiva's Cash from Investing Activities history runs 5 years deep, the most recent figure standing at -$28.1 million for Q2 2025.
- In Q2 2025, Cash from Investing Activities changed N/A year-over-year to -$28.1 million; the TTM figure through Jun 2025 stood at -$23.2 million (changed N/A YoY), while the FY2025 annual figure was -$155.0 million, down 1759.03% from the prior year.
- Cash from Investing Activities was -$28.1 million for Q2 2025 at Inventiva, down from -$273426.3 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $7.7 million in Q1 2021 to a low of -$28.1 million in Q2 2025.
- Historically, Cash from Investing Activities has averaged -$2.9 million across 3 years, with a median of -$276534.1 in 2022.
- The sharpest annual moves came in 2021 and 2022: Cash from Investing Activities soared 553.88% in 2021, then tumbled 105.04% in 2022.
- A 3-year view of Cash from Investing Activities shows it stood at $5.4 million in 2021, then sank by 105.04% to -$273426.3 in 2022, then plunged by 10166.56% to -$28.1 million in 2025.
- The last three Cash from Investing Activities figures came in at -$28.1 million (Q2 2025), -$273426.3 (Q4 2022), and -$279641.8 (Q3 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -2.89 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 638.50 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -431.90 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 579,519.10 |
| 10 | Inventiva | 8.52 Mn | -260.21 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -28.07 Mn |
| Jun 30, 2025 | -28.07 Mn |
| Dec 31, 2022 | -273,426.29 |
| Dec 31, 2022 | -273,426.29 |
| Sep 22, 2022 | -279,641.81 |
| Sep 22, 2022 | -279,641.81 |
| Dec 31, 2021 | 5.42 Mn |
| Dec 31, 2021 | 5.42 Mn |
| Jun 30, 2021 | -1.97 Mn |
| Jun 30, 2021 | -1.97 Mn |
| Mar 31, 2021 | 7.69 Mn |
| Mar 31, 2021 | 7.69 Mn |
| Dec 31, 2020 | -1.19 Mn |
| Dec 31, 2020 | -1.19 Mn |
| Dec 31, 2019 | -928,678.76 |
| Dec 31, 2019 | -928,678.76 |